Breast Cancer Survival Analysis Model

(1) Background: Breast cancer (BC)—a leading cause of mortality in women globally—accounts for more than two million cases annually. BC was the most common cancer in Taiwan in 2015 and ranks among the top 10 malignancies in Taiwan. (2) Methods: We established a collection of BC survival and metastas...

Full description

Bibliographic Details
Main Authors: Rong-Ho Lin, Ching-Shun Lin, Chun-Ling Chuang, Benjamin Kofi Kujabi, Yen-Chen Chen
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Applied Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3417/12/4/1971
_version_ 1797483096048664576
author Rong-Ho Lin
Ching-Shun Lin
Chun-Ling Chuang
Benjamin Kofi Kujabi
Yen-Chen Chen
author_facet Rong-Ho Lin
Ching-Shun Lin
Chun-Ling Chuang
Benjamin Kofi Kujabi
Yen-Chen Chen
author_sort Rong-Ho Lin
collection DOAJ
description (1) Background: Breast cancer (BC)—a leading cause of mortality in women globally—accounts for more than two million cases annually. BC was the most common cancer in Taiwan in 2015 and ranks among the top 10 malignancies in Taiwan. (2) Methods: We established a collection of BC survival and metastasis analyses using the Kaplan–Meier, logarithmic test, and Cox proportional hazard models to investigate the association among BC stages, different treatment modalities, and survival rate of patients with BC at various follow-up intervals. We also evaluated whether clinical prognostic factors had univariate and multivariate effects on the survival of patients with BC. Finally, we performed a metastasis analysis using the survival transition rate values of BC stages to develop a Markov chain and semi-Markov simulation model for BC and BC metastasis analysis, respectively. (3) Results: The Kaplan–Meier survival analysis revealed that the risk of BC treated with surgery was lower than that of those who did not receive surgery and the recommended treatment methods should be ranked by survival as follows: surgery, hormone therapy, chemotherapy, and radiation therapy (in descending order of risk). This is attributed to the predicted survival rate which ranges from 99.6% to 91.2%. Moreover, Cox’s treatment method considered the patient’s attributes and revealed a significant difference (<i>p</i> = 0.001). The Markov chain analyses determined the chance of metastasis at each stage, indicating that the lower the stage of BC, the greater the survival rate. (4) Conclusions: Patients’ treatment is influenced by different BC stages, and earlier detection presents better chances of survival and a greater probability of treatment success.
first_indexed 2024-03-09T22:42:02Z
format Article
id doaj.art-daa4589e111a4a598d8721bcde723f94
institution Directory Open Access Journal
issn 2076-3417
language English
last_indexed 2024-03-09T22:42:02Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series Applied Sciences
spelling doaj.art-daa4589e111a4a598d8721bcde723f942023-11-23T18:37:05ZengMDPI AGApplied Sciences2076-34172022-02-01124197110.3390/app12041971Breast Cancer Survival Analysis ModelRong-Ho Lin0Ching-Shun Lin1Chun-Ling Chuang2Benjamin Kofi Kujabi3Yen-Chen Chen4Department of Industrial Engineering and Management, National Taipei University of Technology, Taipei 10608, TaiwanDepartment of Industrial Engineering and Management, National Taipei University of Technology, Taipei 10608, TaiwanDepartment of Information Management, Kainan University, Taoyuan City 33857, TaiwanDepartment of Industrial Engineering and Management, National Taipei University of Technology, Taipei 10608, TaiwanDepartment of Industrial Engineering and Management, National Taipei University of Technology, Taipei 10608, Taiwan(1) Background: Breast cancer (BC)—a leading cause of mortality in women globally—accounts for more than two million cases annually. BC was the most common cancer in Taiwan in 2015 and ranks among the top 10 malignancies in Taiwan. (2) Methods: We established a collection of BC survival and metastasis analyses using the Kaplan–Meier, logarithmic test, and Cox proportional hazard models to investigate the association among BC stages, different treatment modalities, and survival rate of patients with BC at various follow-up intervals. We also evaluated whether clinical prognostic factors had univariate and multivariate effects on the survival of patients with BC. Finally, we performed a metastasis analysis using the survival transition rate values of BC stages to develop a Markov chain and semi-Markov simulation model for BC and BC metastasis analysis, respectively. (3) Results: The Kaplan–Meier survival analysis revealed that the risk of BC treated with surgery was lower than that of those who did not receive surgery and the recommended treatment methods should be ranked by survival as follows: surgery, hormone therapy, chemotherapy, and radiation therapy (in descending order of risk). This is attributed to the predicted survival rate which ranges from 99.6% to 91.2%. Moreover, Cox’s treatment method considered the patient’s attributes and revealed a significant difference (<i>p</i> = 0.001). The Markov chain analyses determined the chance of metastasis at each stage, indicating that the lower the stage of BC, the greater the survival rate. (4) Conclusions: Patients’ treatment is influenced by different BC stages, and earlier detection presents better chances of survival and a greater probability of treatment success.https://www.mdpi.com/2076-3417/12/4/1971breast cancerCox proportional hazardMarkov chainsemi-Markov chainsurvival analysis
spellingShingle Rong-Ho Lin
Ching-Shun Lin
Chun-Ling Chuang
Benjamin Kofi Kujabi
Yen-Chen Chen
Breast Cancer Survival Analysis Model
Applied Sciences
breast cancer
Cox proportional hazard
Markov chain
semi-Markov chain
survival analysis
title Breast Cancer Survival Analysis Model
title_full Breast Cancer Survival Analysis Model
title_fullStr Breast Cancer Survival Analysis Model
title_full_unstemmed Breast Cancer Survival Analysis Model
title_short Breast Cancer Survival Analysis Model
title_sort breast cancer survival analysis model
topic breast cancer
Cox proportional hazard
Markov chain
semi-Markov chain
survival analysis
url https://www.mdpi.com/2076-3417/12/4/1971
work_keys_str_mv AT rongholin breastcancersurvivalanalysismodel
AT chingshunlin breastcancersurvivalanalysismodel
AT chunlingchuang breastcancersurvivalanalysismodel
AT benjaminkofikujabi breastcancersurvivalanalysismodel
AT yenchenchen breastcancersurvivalanalysismodel